Products for Research Use Only

Aminoglutethimide

CAT: 0804-HY-B0237-01Size: 100 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-B0237-01Size:100 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Aminoglutethimide is an aromatase inhibitor with IC50 of 10 μM. Target: Aromatase Aminoglutethimide inhibits ACTH receptor (ACTH-R) mRNA expression in ovine adrenocortical cells in a time-dependent fashion. Aminoglutethimide significantly suppresses steroid secretion and the baseline ACTH-R mRNA expression in a dose-dependent fashion (300 μM AG, 5±1%; 30 μM AG, 64±1%; 3 μM AG, 108±19% compared with control cells, 100±11%) by affecting the gene expression or by decreasing transcript accumulation via an effect on RNA stability, in the human NCI-h295 adrenocortical carcinoma cell line, which expresses functional ACTH receptors and produces steroids of the glucocorticoid, mineralocorticoid and androgen pathway [1, 2]. Aminoglutethimide (150 mg/kg) abolishes the induction of ornithine decarboxylase (ODC) and almost depletes the gonads and plasma of progesterone or testosterone elicited by human chorionic gonadotropin (hCG) in the ovary of adult female mice and the testis of immature male mice, which is related to an inhibition of cAMP-dependent protein kinase (IC50 287 μM) rather than blockade of the steroidogenic pathway [3].
CAS Number
125-84-8
Product Name Alternative
DL-Aminoglutethimide
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Cytochrome P450
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Endocrinology
Assay Protocol
https://www.medchemexpress.com/aminoglutethimide.html
Concentration
10mM
Purity
98.79
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(C(CC)(C1=CC=C(N)C=C1)CC2)NC2=O
Molecular Formula
C13H16N2O2
Molecular Weight
232.28
Precautions
H302, H315, H319, H335
References & Citations
[1]Fassnacht, M., et al., Aminoglutethimide suppresses adrenocorticotropin receptor expression in the NCI-h295 adrenocortical tumor cell line. J Endocrinol, 1998. 159 (1) : p. 35-42.|[2]Neves, M.A., et al., An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors. Eur J Med Chem, 2009. 44 (10) : p. 4121-7.|[3]Bastida, C.M., et al., Aminoglutethimide, a steroidogenesis inhibitor, abolishes hormonal induction of ornithine decarboxylase in steroidogenic tissues: evidence for its role as cAMP-dependent protein kinase inhibitor. Biochem Biophys Res Commun, 2001. 281 (1) : p. 244-8.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
Aromatase/CYP19A1